97
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Surgical treatment of a primary malignant pericardial mesothelioma: case report

, , , &
Pages 48-50 | Received 25 Oct 2019, Accepted 19 Feb 2020, Published online: 18 Mar 2020

References

  • Thomason R, Schlegel W, Lucca M, et al. Primary malignant mesothelioma of the pericardium case report and literature review. Tex Heart Inst J. 1994;21(2):170–174.
  • Restrepo CS, Vargas D, Ocazionez D, et al. Primary pericardial tumors. Radiographics. 2013;33(6):1613–1630.
  • Feng X, Zhao L, Han G, et al. A case report of an extremely rare and aggressive tumor: primary Malignant Pericardial Mesothelioma. Rare Tumors. 2012;4(2):e21.
  • Butz T, Faber L, Langer C. Primary malignant pericardial mesothelioma – a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case report. J Med Case Rep. 2009;3:9256.
  • Cao S, Jin S, Cao J, et al. Malignant Pericardial Mesothelioma: a systematic review of current practice. Herz. 2018;43(1):61–68.
  • Fernandes R, Nosib S, Thomson D, et al. A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction. BMJ Case Rep. 2014;2014:bcr2013203194.
  • Tada Y, Suzuki T, Shimata H, et al. Molecular-targeted therapy for malignant mesothelioma. PLEURA. January-December 2015;I–II.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.